Pyros and Anovo Partner to Elevate Care for Infantile Spasms
April 1, 2024
Pyros Pharmaceuticals works to elevate the standard of care for children with rare disease by pioneering treatment options like VIGPODER™ (vigabatrin), a breakthrough treatment for infantile spasms.
What is West syndrome?
Infantile spasms, sometimes called West syndrome, are a type of seizure that affects babies. Although symptoms usually begin to show when infants are between 4 and 7 months old, spasms can start any time in the first few years of life. Infantile spasms look like a sudden stiffening of the muscles and occur in short bursts of about one to two minutes at a time – and affected babies can experience up to 100 seizures per day. Children with infantile spasms require treatment quickly after the onset of spasms or there is a risk of negative effects on the development of the child’s brain.
Pyros Pharmaceuticals Partners with Anovo
Our team at Anovo would like to extend heartfelt congratulations to Pyros Pharmaceuticals for the launch of VIGPODER™ (vigabatrin). We are honored to be chosen as the exclusive distributor and specialty pharmacy for this innovative medication. We believe in the potential of VIGPODER™ and its capacity to make a meaningful difference in the lives of those affected by infantile spasms.
Related Posts
Cycle Pharmaceuticals and Anovo Deliver Relief to Those with Homozygous Cystinuria
Cycle Pharmaceuticals was founded in 2012 with one mission in mind: delivering best-in-class drug treatments and services to the underserved…
July 29, 2024
Advancing Rare Disease Care: Insights from the World Orphan Drug Congress and AAN Annual Meeting
The World Orphan Drug Congress (WODC) and the American Academy of Neurology (AAN) Annual Meeting are where healthcare leaders, advocates,…
June 11, 2024
Jill’s Story: Advocating for Patients with Acromegaly
Jill Sisco isn’t just an advocate – she’s also a patient herself. She’s been living with Acromegaly, a rare disease…
March 6, 2024
